MBBS, DCH, FRCP, FRANZCR
Associate Professor N. Kumar Gogna is a senior Radiation Oncologist at Radiation Oncology Centres (ROC) Greenslopes, Redland and Springfield.
Dr Gogna trained as a radiation oncologist at the St Vincent's Hospital in Sydney and for the last 20 years has been based at the Radiation Oncology Mater Centre in Brisbane.
Dr Gogna is one of the founding directors of the Radiation Oncology Queensland (now known as ROC) at the St Andrews Hospital in Toowoomba. Over the last 9 years Dr Gogna and his colleagues have been passionate about taking oncological services to regional and remote areas of the country. He is vastly experienced and has special interests in the treatment of prostate and bladder cancers, head and neck tumours and lymphomas. He has expertise in seed implant therapy for the management of early stage prostate cancer and was instrumental in setting up the first seed brachytherapy programme in Queensland.
He is actively involved in research activities especially pertaining to the betterment of treatments for urological cancers through the Trans Tasman Radiation Oncology Group (TROG) in Australia. In addition, Dr Gogna was previously a member of the executive board of the Faculty of Radiation Oncology with the Royal Australia and New Zealand College of Radiologists (RANZCR). Currently he is actively involved in the teaching and mentoring of trainee registrars in radiation oncology and is an examiner in pathology for the Part II of the fellowship examination held by the RANZCR. Dr Gogna is held in high regard by his colleagues across Australia and New Zealand.
Australian Cancer Network Management of Metastatic Prostate Cancer Working Party. (2010). Clinical Practice Guidelines for the Management of Locally Advanced and Metastatic Prostate Cancer. Sydney: Cancer Council Australia.
Denham, J., Joseph, D., Lamb, D., Spry, N., Duchesne, G., & Matthews, J. et al. (2014). Short-term androgen suppression and radiotherapy versus intermediate-term androgen suppression and radiotherapy, with or without zoledronic acid, in men with locally advanced prostate cancer (TROG 03.04 RADAR): an open-label, randomised, phase 3 factorial trial. The Lancet Oncology, 15(10), 1076-1089. http://dx.doi.org/10.1016/s1470-2045(14)70328-6
Denham, J., Nowitz, M., Joseph, D., Duchesne, G., Spry, N., & Lamb, D. et al. (2014). Impact of androgen suppression and zoledronic acid on bone mineral density and fractures in the Trans-Tasman Radiation Oncology Group (TROG) 03.04 Randomised Androgen Deprivation and Radiotherapy (RADAR) randomized controlled trial for locally advanced pr. BJU International, n/a-n/a. http://dx.doi.org/10.1111/bju.12497
Denham, J., Steigler, A., Joseph, D., Lamb, D., Spry, N., & Duchesne, G. et al. (2015). Radiation dose escalation or longer androgen suppression for locally advanced prostate cancer? Data from the TROG 03.04 RADAR trial. Radiotherapy and Oncology, 115(3), 301-307. http://dx.doi.org/10.1016/j.radonc.2015.05.016
Denham, J., Wilcox, C., Joseph, D., Spry, N., Lamb, D., & Tai, K. et al. (2012). Quality of life in men with locally advanced prostate cancer treated with leuprorelin and radiotherapy with or without zoledronic acid (TROG 03.04 RADAR): secondary endpoints from a randomised phase 3 factorial trial. The Lancet Oncology, 13(12), 1260-1270. http://dx.doi.org/10.1016/s1470-2045(12)70423-0
Foroudi, F., Pham, D., Rolfo, A., Bressel, M., Tang, C., & Tan, A. et al. (2014). The outcome of a multi-centre feasibility study of online adaptive radiotherapy for muscle-invasive bladder cancer TROG 10.01 BOLART. Radiotherapy and Oncology, 111(2), 316-320. http://dx.doi.org/10.1016/j.radonc.2014.02.015
Gogna, N., Baxi, S., Hickey, B., Baumann, K., Burmeister, E., & Holt, T. (2012). Split-Course, High-Dose Palliative Pelvic Radiotherapy for Locally Progressive Hormone-Refractory Prostate Cancer. International Journal of Radiation Oncology*Biology*Physics, 83(2), e205-e211. http://dx.doi.org/10.1016/j.ijrobp.2011.12.028
Hindson, B., Turner, S., Millar, J., Foroudi, F., Gogna, N., & Skala, M. et al. (2012). Australian & New Zealand Faculty of Radiation Oncology Genito-Urinary Group: 2011 consensus guidelines for curative radiotherapy for urothelial carcinoma of the bladder. Journal of Medical Imaging and Radiation Oncology, 56(1), 18-30. http://dx.doi.org/10.1111/j.1754-9485.2011.02336.x
Morgan, G., Barton, M., Atkinson, C., Millar, J., Gogna, N., & Yeoh, E. (2010). ‘GAP’ in radiotherapy services in Australia and New Zealand in 2009. Journal of Medical Imaging and Radiation Oncology, 54(3), 287-297. http://dx.doi.org/10.1111/j.1754-9485.2010.02172.x
Thiruthaneeswaran, N., Turner, S., Milross, C., & Gogna, K. (2014). Promoting a Research Culture among Junior Radiation Oncologists: Outcomes from the Introduction of the Australian and New Zealand Research Requirement in Training. Clinical Oncology, 26(3), 162-173. http://dx.doi.org/10.1016/j.clon.2013.12.007
Woo, H., Begbie, S., Gogna, K., Mainwaring, P., Murphy, D., & Parnis, F. et al. (2014). Multidisciplinary consensus: A practical guide for the integration of abiraterone into clinical practice. Asia-Pacific Journal of Clinical Oncology, 10(3), 228-236. http://dx.doi.org/10.1111/ajco.12264
MBBS, FRANZCR, MD
Associate Professor Michael Poulsen is a Radiation Oncologist at Icon Cancer Centre North Lakes, as well as Mater Centre South Brisbane.
Dr Poulsen is a senior radiation oncologist at the Mater Centre and has been a radiation oncologist with Queensland Health since 1986. He underwent his training the Royal Brisbane and Women’s Hospital (RBWH) and in 1989 spent time at the Royal Marsden Hospital in London. He is also one of the founding directors of Radiation Oncology Queensland (now ROC) which continues to operate a private radiation oncology facility in Toowoomba.
Dr Poulsen has published extensively in the area of radiation oncology. The main areas of interest have been in head and neck cancer, skin cancer with a special interest in Merkel cell carcinoma of the skin. Through his involvement in the Trans Tasman Radiation Oncology Group (TROG) as a principal investigator for TROG 91.01 and 96.07, he has established an international network. This has included published articles on Phase II and III trials and a meta-analysis of fractionation trials for radiotherapy of the head and neck. Research collaboration has been with other radiation oncologists in Australia and New Zealand as well as medical oncologists, allied health professionals and surgeons.
Dr Poulsen’s main areas of interest are in head and neck cancer and skin cancer. He also attends the Mater Private Breast Cancer Centre as a visiting consultant.
MBChB, MSc, MD, FRANZCR, FRCP
Associate Professor Jonathan Ramsay is a consultant Radiation Oncologist at Radiation Oncology Centres (ROC) Redland as well as Mater Centre South Brisbane.
In 2007 Dr Ramsay and two of his colleagues started Radiation Oncology Queensland, now ROC, and is still a consulting radiation oncologist at its centres. He is also a Director of Icon Group.
Dr Ramsay completed his undergraduate research in the United Kingdom, achieving a medical degree at the University of Bristol and pursued postgraduate study at the University of London. Prior to beginning work in Australia, Dr Ramsay held a position for four years as clinical scientist with the University of Cambridge, and for two years as a research fellow with Harvard Medical School in the United States of America.
He continues to have an interest in clinical research having previously spent two years as a Fellow at Harvard Medical School and four years at Cambridge University Department of Clinical Oncology. In 2000 he was involved in the start up of Peplin Biotechnology which developed successful treatments for skin cancers. His clinical practice has been based in South Brisbane since 1994.
Dr Ramsay’s special interests include the treatment of breast and gynaecological cancers.
BSc(Hons), MBBS(Hons), FRANZCR
Dr Angela Allen is a consultant Radiation Oncologist at Radiation Oncology Centres (ROC), Springfield.
Dr Allen graduated with a Bachelor of Science (Hons) at The University of California at Santa Barbara in 2002. She completed her medical degree with Honours at The University of Queensland in 2006. She undertook specialist training in Radiation Oncology at the Peter MacCallum Cancer Centre in Melbourne, Victoria and was awarded fellowship to the Royal Australian and New Zealand College of Radiologists (FRANZCR) in 2014.
She worked as a Radiation Oncologist at the Waikato Hospital in Hamilton, New Zealand where she was actively involved in the teaching and mentoring of trainees in her role as Director of Training. As the clinical lead for the breast working group she gained experience in advanced radiotherapy techniques for breast cancer including deep inspiration breath hold.
Dr Allen is a passionate patient advocate and is a member of the Media and Profile Committee for RANZCR, which promotes the Targeting Cancer campaign, an Australian and New Zealand initiative aimed at raising awareness and improving access to radiation therapy (www.targetingcancer.com.au).
Dr Allen believes in a patient-centred approach and is passionate about improving a patient’s experience during cancer treatment. She has been a consultant for ROC since August 2016. Dr Allen has a wide scope of practice with special interests in breast, lung, prostate, skin and haematological malignancies.
MBBS, DNB (Gold Medallist), FRANZCR
Dr Preeti Bagga is a consultant Radiation Oncologist at Radiation Oncology Centres (ROC), Gold Coast University Hospital.
Dr Bagga completed a Bachelor of Medicine Bachelor of Surgery (MBBS) in 2002 through the Bharati Vidyapeeth Medical College and Deemed University, Pune, India. Dr Bagga completed her initial training in India at Rajiv Gandhi Cancer Institute and Research Centre where she achieved an award for high standards of academia. In 2006 Dr Bagga was awarded the Gold Medal by the National Board of Examinations (India) for scoring the highest marks in the radiation oncology examination within the Diplomate of National Board (DNB).
Dr Bagga completed overseas clinical placement at Memorial Sloan Kettering Cancer Institute in New York with a particular interest in cancers of the prostate.
In 2012, Dr Bagga was awarded fellowship to the Royal Australian and New Zealand College of Radiologists (FRANZCR) Dr Bagga has also been successfully completed part one of the examinations for fellowship at the Royal College of Radiologists in the United Kingdom (FRCR).
Dr Bagga has special interests in head and neck, gynaecology, breast, lower gastrointestinal and prostate cancer.
Bagga, P., Anand, A., Agarwal, P., Chaudhory, A., Sinha, S., & Babu, A. et al. (2009). Comparative Analysis of Dose Distribution and Acute Toxicity with Intensity Modulated Radiation Therapy (IMRT) vs. Conventional Radiation Therapy in Gastric Carcinoma. International Journal of Radiation Oncology Biology Physics, 75(3), S279. doi.org/10.1016/j.ijrobp.2009.07.643
Bagga, P., Anand, A. K., Negi, P. S., Munjal, R. K., Raina, A., Chaudhoory, A. R., & Kumar, K. (2008). Intraoperative brachytherapy in the management of high-risk neck node metastasis: Two case reports from Rajiv Gandhi Cancer Institute. Brachytherapy, 7(2), 166-166. doi:10.1016/j.brachy.2008.02.230
Bagga, P., Anand, A., Raina, A., Choudhary, P., & Chaudhoory, A. (2007). Evaluation of pilocarpine for the prevention of radiation induced xerostomia in head and neck cancers. Annals of Oncology, 18(Supplement 9), ix176-ix177. doi.org/10.1093/annonc/mdm320
Bagga, P., Agarwal, P., Datta, N., Dewan, A., & Garg, C. (2012). Oral tuberculosis following successful treatment of oral malignancy. Journal of Cancer Research and Therapeutics, 8(4), 650-651. doi:10.4103/0973-1482.106590
MBBS, FRACP, FRANZCR
Dr Samantha Barbour is a Radiation Oncologist at ROC Greenslopes. She graduated from medical school at the University of Queensland in 1997. She completed a fellowship in Paediatric Oncology in Brisbane in 2006. This training was undertaken at The Royal Children’s Hospital in Brisbane, The Bristol Royal Hospital for Children in the UK and the Memorial Sloan-Kettering Cancer Center in the USA. Training at leading international centres has provided her with a broad view of cancer care.
After returning to Brisbane and working as a consultant Paediatric Oncologist at the Royal Children’s Hospital, she commenced Radiation Oncology training in Brisbane in 2011. In early 2015, she completed the Fellowship examination and was awarded the Uhr Clark Bursary Award for the phase 2 RANZCR examination. She then worked as a Radiation Oncology Fellow at The Princess Alexandra Hospital with a clinical and research focus on breast cancer, lymphoma and gastrointestinal malignancy. She was awarded a Fellowship in Radiation Oncology in February 2016 and has subsequently worked as a consultant at the Princess Alexandra Hospital and Radiation Oncology Mater Centre.
Dr Barbour is dedicated to lifelong learning and provision of the highest quality of care and clinical outcomes. She has a strong interest in research and has actively recruited patients into clinical trials.
She has an interest in a broad range of cancers with special interest in breast cancer, lymphoma, gastrointestinal cancers, lung cancer and paediatric cancers.
MBBS (Hons) FRANZCR
Dr Rebecca Chin is a consultant Radiation Oncologist at Radiation Oncology Centres (ROC), Wahroonga.
Dr Chin graduated with honours from the University of NSW and trained at the Prince of Wales Hospital in Sydney. Dr Chin is a highly experienced radiation oncologist and has extensive experience in brachytherapy, treating gynaecological cancers.
Dr Chin holds clinics at St Leonards, Strathfield Breast Centre, Castle Hill as well as the Sydney Adventist Hospital. Dr Chin attends regular multidisciplinary team meetings and also attends international meetings along with visits to major cancer institutions nationally and internationally. She has been involved in committees with the Cancer Institute of NSW developing guidelines for breast and gynaecological cancers.
Professional memberships include Royal Australia and New Zealand College of Radiologists, American Brachytherapy Society, American Society for Radiation Oncology, European Society for Medical Oncology, Australia New Zealand Gynaecological Oncology Group. Dr Chin is also a Clinical Lecturer at Sydney Medical School, University of Sydney.
Chin, R., Fisher, R. J., Smee, R. I., & Barton, M. B. (1995). Oropharyngeal cancer in the elderly. International Journal of Radiation Oncology, Biology, Physics, 32(4), 1007-1016. doi:10.1016/0360-3016(95)00515-Z
Mountford, C., Stanwell, P., Ferrier, A., Bourne, R., Doran, S., & Christie, J. et al. (2005). In Vivo Spectroscopy and Imaging of the Ovary in Vivo at 3 Tesla and Spectroscopy on Biopsy at 8.5 Tesla. Journal of Women's Imaging, 7(2), 71-76. http://dx.doi.org/10.1097/01.jwi.0000170626.02187.22
Yuile, P., Chin, R., & Izard, M. (1997). Age-related macular degeneration: a leading cause of blindness. The Medical Journal of Australia, 166(6), 331.
BHB, MBChB, FRANZCR
Dr LeeNa Chong is a consultant Radiation Oncologist at Radiation Oncology Centres (ROC), Wahroonga. Dr Chong also sees patients for consultation at her Chatswood clinic every Saturday. For more information on her Chatswood consults please contact the Chatswood Consulting Rooms on 02 9411 8200.
Dr Chong graduated from the University of Auckland School of Medicine New Zealand. Working across many hospitals in Sydney, Dr Chong underwent physician training at Concord Repatriation and General Hospital and completed specialty training at Westmead and Nepean Cancer Care Centres. She gained fellowship to the Royal Australian and New Zealand College of Radiology (FRANZCR) in October 2008.
She has presented at the Annual Scientific Meeting of the Royal Australasian College of Radiologists and published in the area of treatment of non-melanoma skin cancer in the Journal of Medical Imaging and Radiation Oncology. She has an ongoing special interest in the best practice management of melanoma and non-melanomatous skin cancers. Prior to her current position, Dr Chong worked as a staff specialist at the Breast Cancer Institute, Westmead Hospital.
In addition to breast and skin cancer, her interests include the treatment of lung cancer, palliative care, gastrointestinal cancers, sarcomas and haematological malignancies. She is currently investigating differing fractionation schedules and the role of brachytherapy in management of aggressive sarcomas.
Dr Chong is a clinical tutor for University of Sydney medical program based at the Sydney Adventist Hospital Clinical School. She actively supports and collaborates with medical and surgical oncologists in multi-centre clinical trials. Dr Chong is fluent in Mandarin. She follows an integrated approach to patient management and actively participates in multidisciplinary team conferences to elevate the level of care for oncology patients.
MBChB, MMED, FCRadOnc (SA), Dip Palliative Medicine, FRANZCR, MBA
Dr Colin Dicks is a consultant Radiation Oncologist at Radiation Oncology Centres (ROC), Maroochydore.
Dr Dicks completed schooling in Johannesburg, South Africa before completing an undergraduate medical degree at the University of Pretoria in 1990. Dr Dicks then completed a Master of Medicine (Radiation Oncology) in 1998. After graduating in South Africa, he moved to New Zealand where he completed the Fellow of the Royal Australian and New Zealand College of Radiologists (FRANZCR) qualification and Diploma in Palliative Medicine (Cardiff).
After returning to South Africa for a year, he was offered a position on the Sunshine Coast, where he has been practising as a radiation oncologist since 2004. Since then he has completed a Masters of Business Administration (MBA), published a book, ‘About Dying: How to live in the face of death’ and developed a website www.dyingtounderstand.com that addresses the challenges around death and dying.
Dr Dicks has extensive experience and special interest in lung, prostate and breast malignancies as well as palliative care and psychosocial issues within oncology.
Dr Renee Finnigan is a consultant Radiation Oncologist at Radiation Oncology Centres (ROC), Gold Coast.
Dr Finnigan obtained her medical degree at the University of Newcastle in 2005 and completed her internship and residency at Cairns Base Hospital and Mater Misericordiae Health Services, Brisbane.
During her radiation oncology specialist training, Dr Finnigan rotated through metropolitan and regional training centres across the Queensland network and was awarded fellowship to the Royal Australian and New Zealand College of Radiologists (FRANZCR) in 2013.
Completing a clinical and research fellowship at Princess Alexandra Hospital, Dr Finnigan specialised in the areas of intra-cranial stereotactic radiotherapy/radiosurgery (SRT/SRS) and stereotactic body radiotherapy (SBRT/SABR).
Dr Finnigan remains actively involved in clinical research, holding memberships with the Trans-Tasman Radiation Oncology Group (TROG) and the Cooperative Trials Group for Neuro-Oncology (COGNO).
As a passionate advocate for cancer medical education, Dr Finnigan is the Queensland representative for the RANZCR Targeting Cancer Medical Student Education Working Group. Alongside this position, Dr Finnigan is also an associate lecturer for University of Queensland and is regularly involved in teaching medical students from Griffith and Bond Universities.
Dr Finnigan is a radiobiology tutor for the Queensland Radiation Oncology Trainee Network and convenor for the annual RANZCR Statistics Workshop. She regularly attends and presents lectures for the Gold Coast Cancer Care Collaborative Group. She continues to update her knowledge through literature review and attendance at national and international workshops and conferences.
Dr Finnigan has a wide-ranging practice with particular interest in breast, prostate, skin, lung and haematological malignancies. She participates in regular multidisciplinary team meetings and believes in a holistic approach to patient care.
Finnigan, R., Burmeister, B., Barry, T., Jones, K., Boyd, J., Pullar, A., Foote, M. (2015). Technique and early clinical outcomes for spinal and paraspinal tumours treated with stereotactic body radiotherapy. Journal of Clinical Neuroscience: Official Journal of the Neurosurgical Society of Australasia, 22(8), 1258-1263. doi:10.1016/j.jocn.2015.01.030
Finnigan, R., Hruby, G., Wratten, C., Keller, J., Tripcony, L., Dickie, G., Poulsen, M. (2013). The impact of preradiation residual disease volume on time to locoregional failure in cutaneous merkel cell carcinoma--a TROG substudy. International Journal of Radiation Oncology, Biology, Physics, 86(1), 91.
Finnigan, R., Lamprecht, B., Barry, T., Jones, K., Boyd, J., Pullar, A., Foote, M. (2015). Inter- and intra-fraction motion in stereotactic body radiotherapy for spinal and paraspinal tumours using cone-beam CT and positional correction in six degrees of freedom: Positional error in spine SBRT. Journal of Medical Imaging and Radiation Oncology, n/a. doi:10.1111/1754-9485.12353
BSc (Med), MBBS, MeH, FRANZCR
Dr Andrew Fong is a consultant Radiation Oncologist at Radiation Oncology Centres (ROC), Wahroonga.
Dr Fong graduated from the University of New South Wales in 2000, and has undertaken specialty training at Prince of Wales Hospital and the Royal North Shore Hospital. He was awarded fellowship of the Royal Australian and New Zealand College of Radiologists (FRANZCR) in 2009. Dr Fong also completed a Masters of Electronic Healthcare (MeH) at the University of Queensland, and was awarded the Dean’s Commendation for High Achievement in both 2008 and 2010.
Dr Fong was the inaugural Withers and Peters Fellow for RANZCR in 2009 and focused on research at the Collaboration for Cancer Outcomes, Research and Evaluation (CCORE) and also at Liverpool Hospital. He has been actively involved in teaching at the Northern Clinical School, University of Sydney as well as having an appointment as a conjoint associate lecturer at the University of New South Wales. Dr Fong is also Chair of the RANZCR Website Management Committee, with a focus on electronic learning. He is also an active member of Trans-Tasman Radiation Oncology Group (TROG) and American Society of Clinical Oncology (ASCO).
Dr Fong has particular interests in breast, lung, head and neck cancers, as well as intensity modulated radiation therapy and stereotactic radiosurgery and stereotactic ablative body radiotherapy.
Fong, A., Shafiq, J., Saunders, C., Thompson, A., Tyldesley, S., & Olivotto, I. et al. (2012). A comparison of surgical and radiotherapy breast cancer therapy utilization in Canada (British Columbia), Scotland (Dundee), and Australia (Western Australia) with models of “optimal” therapy. The Breast, 21(4), 570-577. http://dx.doi.org/10.1016/j.breast.2012.02.014
Fong, A., Shafiq, J., Saunders, C., Thompson, A., Tyldesley, S., & Olivotto, I. et al. (2012). A comparison of systemic breast cancer therapy utilization in Canada (British Columbia), Scotland (Dundee), and Australia (Western Australia) with models of “optimal” therapy. The Breast, 21(4), 562-569. http://dx.doi.org/10.1016/j.breast.2012.01.006
Fong, A., Ng, W., Barton, M., & Delaney, G. (2010). Estimation of an evidence-based benchmark for the optimal endocrine therapy utilization rate in breast cancer. The Breast, 19(5), 345-349. http://dx.doi.org/10.1016/j.breast.2010.02.006
Fong, A., Sidhom, M., Hayden, A., & Thiagarajan, A. (2009). Virtual study groups: Internet-based collaborative revision for the FRANZCR examinations. Journal of Medical Imaging and Radiation Oncology, 53(3), 301-304. http://dx.doi.org/10.1111/j.1754-9485.2009.02068.x
Fong, A., Bromley, R., Beat, M., Vien, D., Dineley, J., & Morgan, G. (2009). Dosimetric comparison of intensity modulated radiotherapy techniques and standard wedged tangents for whole breast radiotherapy. Journal of Medical Imaging and Radiation Oncology, 53(1), 92-99. http://dx.doi.org/10.1111/j.1754-9485.2009.02043.x
Lim, L., Chao, M., Shapiro, J., Millar, J., Kipp, D., & Rezo, A. et al. (2007). Long-Term Outcomes of Patients with Localized Rectal Cancer Treated with Chemoradiation or Radiotherapy Alone Because of Medical Inoperability or Patient Refusal. Diseases of the Colon & Rectum, 50(12), 2032-2039. http://dx.doi.org/10.1007/s10350-007-9062-x
Dr Jim Jackson is a Radiation Oncologist at Radiation Oncology Centres (ROC), Gold Coast. He completed his medical degree (MBBS) at the University of Queensland in 2004. Prior to this Dr Jackson had completed a Bachelor of Arts in Psychology at the University of California, Los Angeles (UCLA) and is currently a PhD candidate at Monash University, where he is investigating methods to reduce side effects of cancer treatment.
Dr Jackson completed his Radiation Oncology training in Queensland and in 2012. He undertook a clinical research fellowship at the Austin Health: Olivia Newton-John Cancer and Wellness Centre in Image Guided and Intensity Modulated Radiation Therapy (IMRT). In January 2014, he joined ROC Gold Coast bringing his expertise in providing state-of-the-art treatment techniques including stereotactic radiation therapy for lung and brain tumours.
Dr Jackson has special interests in head and neck, prostate, skin and breast cancers. He enjoys teaching medical students and is a research supervisor for Radiation Oncology trainees and university students. He holds appointments as Honorary Adjunct Assistant Professor at Bond University and Senior Lecturer in Medicine at Griffith University.
He is a member of the ROC Research Committee and has held several roles with the Royal Australia and New Zealand College of Radiologists (RANZCR), at a national level. In October 2016, he served as scientific co-convenor for the RANZCR Annual Scientific Meeting, at the Gold Coast Exhibition and Convention Centre. He is a member of both the American and European Radiation Oncology Societies and regularly reviews scientific papers for national and international medical journals.
Dr Jackson is passionate about prompt and personalised patient care and high-quality, modern radiation therapy.
Lehman M, Gorayski P, Watson S, Edeling D, Jackson J, Whitty J. Radiother Oncol. 2016 Oct 4. pii: S0167-8140(16)34297-9. doi: 10.1016/j.radonc.2016.09.003. [Epub ahead of print]
Jackson JE, Burmeister BH, Burmeister E, Foote MC, Thomas JM, Smithers BM.
Melanoma Brain Metastases: The Impact of Nodal Disease. Clin Exp Metastasis. 2014 Jan;31(1):81-5. doi: 10.1007/s10585-013-9611-8. Epub 2013 Aug 23.
Kelly SL, Jackson JE, Hickey BE, Szallasi FG, Bond CA. Multidisciplinary Clinic Care Improves Adherence to Best Practice in Head and Neck Cancer. Am J Otolaryngol. 2013 Jan; 34(1): 57-60.
Lin C, Tripcony L, Keller J, Poulsen M, Martin J, Jackson J, Dickie G. Perineural Infiltration of Cutaneous Squamous Cell Carcinoma and Basal Cell Carcinoma Without Clinical Features. Int J Radiat Oncol Biol Phys. 2012 Jan 1;82(1):334-40.
Jackson JE, Dickie GJ, Wiltshire KL, Keller J, Tripcony L, Poulsen MG, Hughes M, Allison RW, Martin JM. Radiotherapyfor Perineural Invasion in Cutaneous Head and Neck Carcinomas: Towards a Risk Adaptive Treatment Approach. Head and Neck. 2009 May; 31 (5) 604-610.
Jackson JE, Dickie GJ, Poulsen MG, Martin JM. Author Reply Existence of MRI-negative clinical (large nerve) perineural squamous cell carcinoma spread. Head and Neck 2009 Nov; 31(11):1532-3.
2015 M Lehman, P Gorayski, R Mujcic, S Watson, D Edeling, J Jackson, J Whitty. Locally Advanced NSCLC: Patient Preferences Regarding Prophylactic Cranial Irradiation – A Discrete Choice Experiment. Oral Presentation at IASCLC 16th World Conference on Lung Cancer Denver, CO USA.
2015 L Nardone, JE Jackson, NJ Anderson, M Rolfo, D Lim Joon, M Wada. Prognostic significance of tumour volume for squamous cell carcinoma of the oropharynx treated with intensity-modulated radiotherapy. Oral Presentation at RANZCR ASM Adelaide.
2015 D Rai, MG Poulsen, L Anderson, M Gibson , M Wada, JE Jackson. Accurate 3D Mandibular VMAT Dose Prediction from 18-FDG PET Derived Auto Contours: Streamlined ORN Prophylaxis. Poster Presentation ESTRO 3rd Forum Barcelona, Spain.
2015 S Pathmanathan, D Rai, MG Poulsen, A Plank, M Gibson, JE Jackson. Improved Access to Radiotherapy for Lung Cancer Impacts Utilisation Rates and Waiting Times. Poster Presentation ESTRO 3rd Forum Barcelona, Spain.
2013 A Lim, JE Jackson, D Lim Joon, CY Hiew, S Sengupta, D Angus, M Chao, V Khoo. Planning MRI in Post-Prostatectomy Radiotherapy: Are we aiming too high? Oral presentation at RANZCR ASM Auckland, NZ 2013.
2013 J. Jackson, N Anderson,M. Wada, M. Schneider-Kolsky, M. Rolfo, H. Gan, K. Kaegi, ST Lee, D. Lim Joon, A. Huynh, V.Khoo. 18F-FDG Metabolic Tumour Volume: Association with Dysphagia Requiring a Feeding Tube in Head and Neck IMRT. Oral Presentation ANZ Head and Neck Cancer Society ASM, Albert Park, VIC 2013.
2013 Fahandej M, Anderson N, Jackson JE, Wada M, Schneider M, Rolfo M, Lim Joon D, Khoo V. Correlation of Grade 3 Dysphagia and Delivered Dose to Specific Swallowing Structures in Definitive IMRT for Head and Neck CancersOral Presentation ANZ Head and Neck Cancer Society ASM, Albert Park, VIC 2013.
2013 Jackson JE, Wada M, Lee ST, Gan H, Poon A, Gong S, Gunawardana D, Lim Joon D, Khaw P, Khoo V, Scott AM. Pre-Radiotherapy [18F]- Misonidazole Positron Emission Tomography Predicts for Long Term Local Control and Survival in Head and Neck Cancer. Oral Presentation ESTRO 2nd Forum in Geneva, Switzerland.
2013 Chu K, Jackson JE, Tan Y, Lim Joon D, Bolton DM, Sengupta S. Contemporary Practice of Radiotherapy Post Radical Prostatectomy at a Tertiary Referral Centre in Australia. Oral Presentation Urological Society of Australia and New Zealand ASM.
2013 Rolfo M, Jackson J, Lim Joon D, Scandurra D, Anderson N, Wada M, Welsh B, Lawlor M, Brown K, Khoo V. Simple Segment IMRT: Dosimetric and Resource Implications of an Innovative Rectal Cancer Technique. ASTRO 55th ASM in Atlanta, USA.
2013 Anderson N, Jackson J, Wada M, Schneider-Kolsky M, Rolfo M, Gan H, Kaegi K, Sneyd F, Lim Joon D, Khoo V. Creating Guidelines for Reactive and Prophylactic Enteral Feeding in Definitive (Chemo) IMRT for Head and Neck Cancer. ASTRO 55th ASM in Atlanta, USA.
2012 Jackson JE, Burmeister BH, Burmeister E, Foote MC, Thomas JM, Smithers BM. Melanoma Brain Metastases: The Impact of Nodal Disease. ASTRO 54th ASM. Boston, USA October 2012
2010 Ratanjee SK, Jackson JE.Erythropoiesis Stimulating Agent Dose and Peritoneal MembraneTransport Status: A Dose Response Relationship. Poster Presentation American Society of Nephrology Annual Meeting, Kidney Week.
2009 Martin JM, Jackson JE, Blyth J, Morrison S, Bryant D, Plank A, Cheuk R, Fay M, Dickie G, Yaxley J.Prostate Volume Changes following HDR Brachytherapy: Implications for Timing of External Beam Planning. Oral Presentation RANZCR ASM.2009.
2007 Jackson JE, Dickie GJ, Wiltshire KL, Keller J, Tripcony L, Poulsen MG, Hughes M, Allison RW, Martin JM. Radiotherapyfor Perineural Invasion in Cutaneous Head and Neck Carcinomas: Towards a Risk Adaptive Treatment Approach. Oral Presentation ANZ Head and neck Society ASM 2007.
Dr Marcel Knesl is a consultant Radiation Oncologist at Radiation Oncology Centres (ROC), Maroochydore.
After completing an undergraduate medical degree (MBChB) at Witwatersrand University in Johannesburg, South Africa, Dr Knesl moved to Auckland, New Zealand where he trained in radiation oncology at Auckland Hospital. During this time Dr Knesl became a fellow of the Royal Australian and New Zealand College of Radiologists.
Dr Knesl began practicing radiation oncology on the Sunshine Coast in 2006 as well as holding academic appointments with the Royal Australian and New Zealand College of Radiologists including Part 1 Examiner in radiation oncology. More recently Marcel completed the Graduate Diploma of Australian Institute of Company Directors.
Dr Knesl’s special interests include breast, gastrointestinal, genitourinary, and lymphoma malignancies.
Dr Samuel Leung is a Radiation Oncologist at Radiation Oncology Centres Toowoomba.
Dr Leung obtained his medical degree from Melbourne University and was awarded fellowship to the Royal Australian and New Zealand College of Radiologists (FRANZCR) in 1979. He is a highly experienced radiation oncologist and has practiced at several hospitals including Royal Melbourne Hospital, Western Heath, Austin Health, Peter McCallum Cancer Institute and Royal Womens Hospital.
He is also actively involved in clinical research and is a member of European Society of Radiation Oncology (ESTRO) and American Society of Radiation Oncology (ASTRO). Dr Leung has a wide-ranging practice with special interest and expertise in gynaecological cancers, breast cancer and brachytherapy. He also has particular interest in lymphoma, lung and urological cancers.
A Comparison Between Low Dose Rate Radiotherapy and Conventionally Fractionated Irradiation in Moderately Extensive Carcinomas of the Oropharynx: B. Pierquin, E. Calitchi, J.J. Mazeron, J.P. LeBourgeois, S. Leung: Int. J. Rad. Onc. Biol. Phys. 11,3 March 1985,431-44
Comparative Dosimetry between Iridium Wire and Seed Ribbons: G. Marinello, M. Valero, S. Leung, B. Pierquin: Int. J. Rad. Onc. Biol. Phys. 11,9 Sept. 1985, 1733-40
Treatment of Bladder Tumours by Iridium 192 Implantation: J.J. Mazeron, G. Marinello, S. Leung: Radiotherapy and Oncology 1985,4: 111-19
Intestinal Complications of Wide Field Abdominal Irradiation for Lymphoma: D. Langlois, J.P. LeBourgeois, S. Leung, M. Kuentz: Radiotherapy and Oncology 1985
Locoregional Recurrences Following External Beam irradiation and Interstitial Implantation for Operable Breast Cancer- A 23 Year Experience: S. Leung, Y. Otmezguine, E. Calitchi, J.J. Mazeron,J.P. LeBourgeois, B.Pierquin: Radiotherapy and Oncology January 1986, 1:1-10
Update on Low Dose Rate Irradiation for Carcinomas of the Oropharynx: B. Pierquin, E. Calitchi, J.J. Mazeron, S. Leung: Int. J. Rad. Onc. Biol. Phys. Feb. 1987,13,2:259-62
Perineal template Techniques for Interstitial Implantation of Gyne. Cancers using the Paris System of Dosimetry: S. Leung: Int. J. Rad. Onc. Biol. Phys. Sept. 1990,19:769-74
Radical Radiotherapy for Ca. Vagina- PMCI Experience 1970- 1990- Impact of Treatment Modality on Outcome: S. Leung, M. Sexton: Int. J. Rad. Onc. Biol. Phys. Feb.1993,25:413-18
Laparoscopic Ovariopexy for Pediatric Pelvic Malignancies: H. Tan, R.J. Scorpio, J.M. Hutson, K. Waters, S. Leung: Pediatric Syrgery International. 1993,8:379-81
Treatment of Pediatric Genitourinary Malignancy with Interstitial Brachytherapy- PMCI Experience with 4 cases: S. Leung. Int. J. Rad. Onc. Biol. Phys. Jan 1995, 31,2:393-8
Letters to the Editor,Re: Should Whole Pelvic Radiation Therapy become Past History? A case for the Routine Use of Extended Field Therapy and Multimodality Therapy: Gynecologic Oncology 1994
Interstitial Ir. 192 for Cutaneous Ca. of the External Nose: J.M. Crook, J.J. Mazeron, G. Marinello, M. Raynal, J. Huart, S. Leung, J.P. LeBourgeois, B. Pierquin: Int. J. Rad. Onc. Biol. Phys. Jan.1990,18,1:43-8
Gynaecologic Radiotherapy Controversies: S. Leung: VCOG Newsletter Gynaecologic Cancer October 1995, 10:8-14
Accelerated Hyperfractionated Radiotherapy for Locally Advanced Cervix Cancer: C.Macleod, D. Bernshaw, S. Leung, K. Narayan, I. Firth: Int. J. Rad. Onc. Biol. Phys. 1999,44,3:519-24
Use of Digitally Reconstructed Radiographs in Radiotherapy treatment Planning and Verification: C. Yang, M.Guiney, P.Hughes, S. Leung, K.H. Liew, J. Matar, G. Quong: Aust. Radiology. Nov. 2000,44,4
Australian High Dose Rate Brachytherapy Protocols for Gynaecological Malignancy: C.Macleod, R.Cheuk, M.Dally, A.Fowler, S.Gauden, S.Leung, C.Milross, K.Narayan, M.Stevens, D.Thornton, S.Carruthers, P.Jeal: Aust. Radiology Feb. 2001, 45,1
BSc (Hons), MBBS (Hons), FRANZCR, DipPallMed (Clinical)
Dr Dominic Lunn is a consultant Radiation Oncologist at Radiation Oncology Centres (ROC), Gold Coast and Redland.
Dr Lunn attended the University of Queensland as an undergraduate and received a first class honours degree in molecular biology before spending several years working in medical research both in Australia and overseas. In 2000, he enrolled in the Bachelor of Medicine Bachelor of Surgery at the University of Queensland, and graduated with honours. He began training in radiation oncology in 2008 was awarded fellowship to the Royal Australian and New Zealand College of Radiologists (FRANZCR) in early 2012. He subsequently completed a fellowship in palliative care at the Mater Hospital in Brisbane and worked as a palliative care specialist and locum radiation oncologist until late 2013 when he was involved in setting up the radiation oncology service at ROC Gold Coast University Hospital.
He is currently director of training at ROC Gold Coast and is actively involved in several clinical trials. He has a special interest in palliative radiation therapy and has a wide scope of practice including the treatment of lung, gynaecological, genitourinary, breast and central nervous system (CNS) malignancies.
Dr Myo Min is a clinician with a strong interest in research. He believes in patient-centred care and is always keen to work with patients and their families in providing evidence-based healthcare. He consults at ROC Maroochydore.
Dr Min completed his specialist training in radiation oncology at Royal Adelaide Hospital, in Adelaide in 2014. He then pursued post-graduate sub-specialist training in head and neck, gastro-intestinal and skin malignancies at Liverpool/Campbelltown Hospitals, in Sydney. During his post training fellowship years, he also undertook a PhD program, at University of New South Wales, investigating the role of functional imaging in head and neck cancer.
He then completed his PhD in medicine in 2016. He is currently a staff specialist (radiation oncology) at the Sunshine Coast University Hospital. His main areas of interest are head and neck cancer, gastrointestinal cancer, lung cancer and skin cancer.
MBBS (Hons), BSc, FRANZCR
Dr Manoja Palliyaguru is a consultant Radiation Oncologist at Radiation Oncology Centres (ROC), Springfield.
Dr Palliyaguru completed a Bachelor of Medicine with Honours (MBBS Hons) at the University of Sydney in 2003. Prior this Dr Palliyaguru had also completed a Bachelor of Science (BSc) majoring in pharmacology and physiology.
Through completion of radiation oncology training in Brisbane at Royal Brisbane and Women’s Hospital, Princess Alexandra and Mater Campus Radiation Oncology Services Dr Palliyaguru was awarded fellowship to the Royal Australia and New Zealand College of Radiologists (FRANZCR) in 2013.
In 2014 Dr Palliyaguru was awarded the Windeyer Fellowship by the RANZCR and was provided the opportunity to undertake a Clinical Research Fellowship in radiation oncology at the Mount Vernon Cancer Centre, Northwood in the United Kingdom. Under the broad supervision of Professor Peter Hoskin, Dr Palliyaguru completed clinical work alongside senior clinical oncologists across multiple subspecialty sites and participated in clinical research projects.
Dr Palliyaguru’s special interests include gynaecology, breast and prostate cancers.
Dr Edward Sun is a consultant Radiation Oncologist at Radiation Oncology Centres (ROC) Gosford.
Dr Sun graduated from the University of Sydney in 1982. He was awarded the NSW State Cancer Council Training Fellowship in radiation oncology in 1984 and undertook specialty training in radiation oncology at Westmead Hospital and the Prince of Wales Hospital between 1984 and 1987. In 1984 he won the C.E. Eddy Prize for being the most successful candidate in D.R.A.C.R. Part 1 examination.
After completing his fellowship, Dr Sun was a senior registrar in radiation oncology at Prince of Wales Hospital, Randwick in 1988 and a locum staff specialist at St. Vincent's Hospital, Darlinghurst in 1989. From 1990 to 1991, Dr Sun was appointed Medical and Health Officer at the Institute of Radiotherapy, Queen Mary Hospital, Hong Kong, gaining experience in head and neck, gynaecological cancers and brachytherapy techniques. In 1992 Dr Sun returned to join the Sydney Radiotherapy and Oncology practice and is currently consulting at the Sydney Adventist Hospital, Hornsby Ku-ring-gai District Hospital and Gosford Private Hospital.
Dr Sun is also a clinical teacher with the University of Sydney and the University of Newcastle. Dr Sun has particular interest in urological, lung and head and neck cancers, stereotactic body radiotherapy techniques, TomoTherapy and brachytherapy treatments of various malignancies including prostate and gynaecological cancers.
BSc (Med), MBBS (Hons), FRANZCR
Dr Amy Yuen Meei Teh is a consultant Radiation Oncologist at Radiation Oncology Centres (ROC) Wahroonga and Gosford.
Dr Teh graduated with honours from the University of New South Wales in 2001. She completed radiation oncology training at the Peter MacCallum Cancer Centre in Melbourne, Australia, followed by a clinical research fellowship at the Princess Margaret Hospital in Toronto, Canada, where she was the recipient of the Phyllis Hantho Breast Cancer Research Fund and was awarded the Weekend to End Breast Cancer Research Fellowship for her research. Dr Teh returned to Australia in 2009 as a consultant radiation oncologist at the Radiation Oncology Institute and Sydney Adventist Hospital.
Dr Teh has special interests in breast cancer and prostate cancer, with certification from the Seattle Prostate Institute, USA for both low dose rate and high dose rate brachytherapy. Dr Teh has an active interest in prostate specific membrane antigen (PSMA) positron emission tomography (PET) imaging and stereotactic adaptive body radiotherapy in prostate cancer, using Tomotherapy, volumetric modulated arc therapy (VMAT) and intensity-modulated radiation therapy (IMRT) and has completed the ESTRO course in image-guided stereotactic radiotherapy from Lille, France.
Dr Teh is a Clinical Senior Lecturer at the Sydney Adventist Hospital Clinical School, Sydney Medical School, University of Sydney, and was awarded Excellence in Teaching in 2014. Dr Teh is also examiner for the Royal Australia and New Zealand College of Radiology (RANZCR).
Dr Teh has been lead author of publications in the International Journal of Radiation Oncology, Biology & Physics (IJROBP) and Journal of Thoracic Oncology. Dr Teh's research on concomitant intensity modulated boost during whole breast hypo-fractionated radiotherapy was published in the Journal of the European Society for Therapeutic Radiology and Oncology (ESTRO). More recently, Dr Teh has presented and published on prostate brachytherapy and the use of SpaceOAR™ in prostate radiotherapy.
Dr Teh’s research has been presented at the American Society for Therapeutic Radiology and Oncology (ASTRO), Urological Society of Australia and New Zealand (USANZ), Royal Australia and New Zealand College of Radiology (RANZCR) and University of Toronto radiation oncology scientific meetings.
A member of Trans-Tasman Radiation Oncology Group (TROG) and Australia and New Zealand Urogenital and Prostate Cancer (ANZUP) clinical trials group, Dr Teh is site-principal-investigator of international trials on post-prostatectomy radiotherapy (RAVES) and the use of adjuvant systemic/ hormone therapy with prostate radiotherapy (ENZARAD).
Dr Teh is research supervisor to University of Sydney medical students. She is a reviewer for the IJROBP and Journal of Medical Imaging and Radiation Oncology (JMIRO). Dr Teh has been invited speaker on prostate and breast cancer management both locally and internationally. Dr Teh was also part of a volunteer oncology team to the Solomon Islands.
Alajez, N., Wang, W., Biswas, D., Teh, A., Sutherland, R., & Pintilie, M. et al. (2011). The effect of local breast radiotherapy on circulating CD34+ cells. Radiotherapy and Oncology, 100(2), 304-307. http://dx.doi.org/10.1016/j.radonc.2011.01.003
Dedic-Hagan, J., Teh, A., Liang, E., Collett, N., & Woo, H. (2014). Migration of a strand of four seeds in low-dose-rate brachytherapy. Case Reports, 2014(may30 2), bcr2014204515-bcr2014204515. http://dx.doi.org/10.1136/bcr-2014-204515
Teh, A., Ball, D., Cassumbhoy, R., & Guglani, S. (2007). Bilateral Patellar Metastases from Non-small Cell Lung Cancer. Journal of Thoracic Oncology, 2(1), 79-80. http://dx.doi.org/10.1097/01243894-200701000-00016
Teh, A., Ball, D., O’Day, J., & Cassumbhoy, R. (2006). Bilateral Choroidal Metastases from Mesothelioma. Journal of Thoracic Oncology, 1(7), 712-713. http://dx.doi.org/10.1097/01243894-200609000-00018
Teh, A., Ko, H., Barr, G., & Woo, H. (2014). Rectal ulcer associated with SpaceOAR hydrogel insertion during prostate brachytherapy. Case Reports, 2014(dec22 1), bcr2014206931-bcr2014206931. http://dx.doi.org/10.1136/bcr-2014-206931
Teh, A., Park, E., Shen, L., & Chung, H. (2009). Three-Dimensional Volumetric Analysis of Irradiated Lung with Adjuvant Breast Irradiation. International Journal of Radiation Oncology*Biology*Physics, 75(5), 1309-1315. http://dx.doi.org/10.1016/j.ijrobp.2008.12.077
Teh, A., Walsh, L., Purdie, T., Mosseri, A., Xu, W., & Levin, W. et al. (2012). Concomitant intensity modulated boost during whole breast hypofractionated radiotherapy - A feasibility and toxicity study. Radiotherapy and Oncology, 102(1), 89-95. http://dx.doi.org/10.1016/j.radonc.2011.10.015
BSc, BA, MBBS, FRAZCR
Dr Angela Yates is a consultant Radiation Oncologist at Radiation Oncology Centres (ROC), Gold Coast.
Dr Yates earned her medical degree at University of Sydney in 2006. She has also completed a Bachelor of Science (Applied Chemistry) and Bachelor of Arts (International Studies). She completed her internship at The Canberra Hospital and residency and training at Hornsby Ku-ring-gai Hospital, St George Hospital and The Chris O’Brien Lifehouse in Sydney and was awarded fellowship to the Royal Australian and New Zealand College of Radiologists (FRANZCR) in 2014. She is currently completing a Master of Medicine in clinical epidemiology at University of Sydney.
Dr Yates has also held positions at St Vincent’s Hospital, Sydney specialising in gastrointestinal and head and neck cancers as well as completing a research fellow in central nervous system and lung cancer at Alfred Hospital, Melbourne at the Radiation Oncology Stereotactic Radiotherapy Clinic.
She is passionate about delivering quality evidence based care to patients in a caring and sensitive manner. Dr Yates also has a strong focus on being actively involved in research, teaching and college activities. She hold memberships with Trans-Tasman Radiation Oncology Group (TROG), Australian and New Zealand Urogenital and Prostate Group (ANZUP) and Australian Gastrointestinal Trials Group (AGITG).
Dr Yates has a wide-ranging practice with particular interests in the treatment of malignant disease, gastrointestinal, head and neck, central nervous system (CNS) and lung cancers.
Yates A, Carroll S, Kneebone A, Tse R, Horvath L, Byrne C, Solomon M, Hruby G,Implementing intensity-modulated radiotherapy with simultaneous integrated boost for anal cancer: three year outcomes at two Sydney institutions, Clin Oncol 2015, 27(12):700-7
Yates A, Segelov E, Meagher J, Pendlebury S, Garland T, Nolan C, The Ten Bed Program: The compassionate care of Solomon Island patients at St Vincent’s Hospital, St Vincent’s Clinic Proceedings Dec 2015, 23(1):20-23
The effect of radiotherapy delay on survival in non-small cell lung cancer (Collaboration of Alfred Health and Liverpool Hospital)
HPV, HIV and survival in anal cancer (10 year cohort St Vincent’s Hospital)
Anal Cancer as a second human papilloma virus (HPV) related tumour: a case series of seven women with prior successful treatment of cervical intraepithelial neoplasia (CIN) -abstract accepted for poster presentation RANZCR ASM 2015, ESTRO 2016